phone+44 203 371 1100

Ligand Pharmaceuticals Incorporated

Credit Sector:- Health Care

Country:- United States

Bond Document:- https://www.bondpdf.com

In order to view the complete data, please login here

List of Corporate Actions

Announcement Date CA Type CA Impact CA Event ISIN
18-Sep-2023 Propose Spin Off Target Name Pelican Technology Holdings, Inc. US00214WAE12
Ligand Pharmaceuticals Incorporated has announced that it intends to spin-off Pelican Technology Holdings, Inc.
17-Jul-2023 Propose Asset Acquisition - - -
Ligand Pharmaceuticals Incorporated today announced that it intends to acquire () from ().
27-Sep-2023 Asset Acquisition - - -
Ligand Pharmaceuticals Incorporated today announced that it has acquired assets of Novan, Inc..
01-Nov-2023 Acquisition Acquired Name Tolerance Therapeutics, Inc. -
Ligand Pharmaceuticals Incorporated today announces that it has acquired Tolerance Therapeutics, Inc..
08-Jul-2024 Propose Acquisition Target Name Apeiron Biologics AG -
Ligand Pharmaceuticals Incorporated today announced that it intends to acquire Apeiron Biologics AG.

View more details

FactEntry

All of the financial data available on this page is sourced from FactEntry.